NCT03618043 2019-01-29Safety and Tolerability of SH-1028 in Patients With Advanced Solid CancerNanjing Sanhome Pharmaceutical, Co., Ltd.Phase 1 Unknown14 enrolled
NCT03603262 2019-01-28Safety, Tolerability and Pharmacokinetics of SH-1028 in Patients With Advanced NSCLCNanjing Sanhome Pharmaceutical, Co., Ltd.Phase 1 Unknown85 enrolled